Cevidoplenib (dimesylate)
Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2].
Product Specifications
CAS Number
[2043659-93-2]
Product Name Alternative
SKI-O-703 (dimesylate)
UNSPSC
12352005
Target
Syk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cevidoplenib-dimesylate.html
Concentration
10mM
Purity
98.96
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(C1CC1)C2=CN(C)C3=C2C=C(NC4=NC=CC(N5N=C(C)C(CN6OC[C@@H](O)C6)=C5)=N4)C=C3.CS(=O)(O)=O.CS(=O)(O)=O
Molecular Formula
C27H35N7O9S2
Molecular Weight
665.74
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 31, No. 4, 2017.|[2]cevidoplenib dimesylate.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Browse additional items from our catalog
Human Phosphoribosylformylglycinamidine Synthase (PFAS) ELISA Kit
Human Phosphoribosylformylglycinamidine Synthase (PFAS) ELISA Kit
Human Phosphoribosylformylglycinamidine Synthase (PFAS) ELISA Kit
SLC39A10 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Lentiviral human CYBB sgRNA gene knockout kit - Lentiviral human CYBB sgRNA gene knockout kit (25)